ATHENS MEDICAL S.A informs the investors that on Monday, 19 November 2007, following the decision 7.16/443/06.09.2007 of the Hellenic Capital Market Commission, the sale of 100.787 registered shares that were not submitted for dematerialization as well as of shares derived from company transactions and issued in dematerialized form in favour of the beneficiaries of the register shares, was completed. EFG EUROBANK Securities, the ASE member that was appointed to carry out the sale, notified that the net result of the sale after deducting related expenses and taxes amounted to EURO 452.372,58. The aforementioned amount will be deposited proportionally within seven (7) working days, in the name of the entitled shareholders, to the Deposits and Loans Fund. The Company will inform by mail all eligible shareholders regarding the collection process, as well as the necessary documentation for this collection. After the aforementioned sale company's shares will be only of dematerialized form. For any further information please contact Company's Investors Servicing Office. (Phone number 210 6862 454).